Equillium, Inc.EQ

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$1.72
Market cap
$109.1M
P/E
—
Revenue (TTM)
—
Net income
-$18.0M
Dividend yield
—
1-year total return
22.9%
Net margin
—
Revenue growth
—
Debt / equity
—

What Equillium, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue——$15.8M$36.1M$41.1M—
Net income-$29.8M-$39.1M-$62.4M-$13.3M-$8.1M-$22.4M
Free cash flow-$24.8M-$32.1M-$9.0M-$21.8M-$19.1M-$22.8M

More on EQ.

Figures from Equillium, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.